Vestor Capital’s Bristol-Myers Squibb BMY Stock Holding History

Vestor Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.6M	Buy	+174,257	New	+$10.2M	0.76%	40
2022 Q2	–	Sell	-566	Closed	-$41K	–	213
2022 Q1	$41K	Buy	+566	New	+$38K	﹤0.01%	227
2021 Q4	–	Sell	-66,872	Closed	-$3.96M	–	235
2021 Q3	$3.96M	Buy	+66,872	New	+$4.4M	0.41%	61
2020 Q1	–	Sell	-3,660	Closed	-$235K	–	140
2019 Q4	$235K	Buy	3,660 +2,500	+216%	+$143K	0.04%	94
2019 Q3	$59K	Buy	+1,160	New	+$54.5K	0.01%	116
2019 Q2	–	Sell	-1,443	Closed	-$69K	–	136
2019 Q1	$69K	Buy	+1,443	New	+$71.9K	0.01%	116

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vestor Capital's BMY Position: Q1 2026 in Review

Vestor Capital opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 174,257 shares worth $10.6M. The stake represents 0.76% of the portfolio and ranks #40 among its holdings. This is a return to the name: Vestor Capital previously reported a position in BMY as recently as Q1 2022.

Vestor Capital first reported a position in BMY in Q1 2019 and has held it in 6 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Vestor Capital held 174,257 shares of Bristol-Myers Squibb worth $10.6M as of Q1 2026.
Bristol-Myers Squibb was a new Vestor Capital position in Q1 2026.
Bristol-Myers Squibb made up 0.76% of Vestor Capital's portfolio in Q1 2026, its #40 holding.
Vestor Capital first reported a position in Bristol-Myers Squibb in Q1 2019 and has held it in 6 quarters since.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Vestor Capital's 13F filing for Q1 2026, filed 21 May 2026.